Company* (Country;
Symbol)

Company* (Country;
Symbol)

Product

Terms/Details (Date)

Discovery Partners International
(DPII)

Mimotopes Pty. Ltd. (subsidiary of Fisher Scientific International Inc.; NYSE:FSH)

Certain products
in Discovery's Irori combinatorial chemistry instruments product line

Discovery Partners named Mimotopes its nonexclusive, worldwide distributor of the products (11/25)

Epoch
Biosciences
Inc. (EBIO)

Qiagen NV (the Netherlands; QGENF)

Products that incorporate Epoch's MGB Eclipse Probe Systems for real-time measurement of gene expression

Epoch will supply components to Qiagen and Qiagen will offer custom and catalog probe systems as part of its gene expression product offerings for sale to researchers in the life sciences industry and to pharmaceutical companies conducting internal research; Qiagen received a nonexclusive license to the component technologies, and Epoch will receive undisclosed technology access fees and would receive royalties on sales of catalog products (11/5)

Invitrogen Corp. (IVGN)

Novozymes
A/S* (Denmark)

rProtease

Novozyme will distribute the product for mammalian and insect cell culture purposes (11/6)

Metabolic Pharmaceuticals Ltd. (Australia; ASX:MBP)

Bresagen Ltd. (Australia; ASX:BGN)

AOD9604

Contracted agreement for Bresagen to develop a large-scale manufacturing method for Metabolic's obesity drug (11/6**)

Notes:

# The information in the chart does not cover agricultural agreements.

* Private companies are indicated with an asterisk.

** Denotes the date the item ran in BioWorld International.

Unless otherwise noted, stock symbols listed are on the Nasdaq market.

ASX = Australian Stock Exchange